Medtronic, Boston Scientific and other medtech leaders are competing to commercialize catheter technology with roots in ...

Atrial fibrillation is a condition which affects 1.4 million people in Britain and ... Chest pain and shortness of breath are ...

VIENNA--AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug ...

U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting ...

Irregular sleep patterns increase the risk of conditions such as stroke, heart failure and heart attacks, regardless of ...